Genetic reduction of Nlk in animal models for SCA1 and SBMA alleviates several disease-related phenotypes, and this partial rescue was previously attributed to decreased phosphorylation of 2 Nlk substrates, ataxin-1 and AR, at key residues involved in the pathogenic mechanisms (7, 8). This evidence concerns the gene AR and spinocerebellar ataxia type 1.